Fluoxetine during Development Reverses the Effects of Prenatal Stress on Depressive-Like Behavior and Hippocampal Neurogenesis in Adolescence

L. Pawluski, Jodi

Fluoxetine during Development Reverses the Effects of Prenatal Stress on Depressive-Like Behavior and Hippocampal Neurogenesis in Adolescence

Posted on 2013-02-20 - 15:09

Stress was administered between GD15-21. Fluoxetine treatment to the mother began 1 day after birth and continued until weaning (P21). Between P32 and P39, offspring were subjected to behavioral tasks. At P42, offspring were sacrificed.

CITE THIS COLLECTION

DataCite

3 Biotech

3D Printing in Medicine

3D Research

3D-Printed Materials and Systems

4OR

AAPG Bulletin

AAPS Open

AAPS PharmSciTech

Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg

ABI Technik (German)

Academic Medicine

Academic Pediatrics

Academic Psychiatry

Academic Questions

Academy of Management Discoveries

Academy of Management Journal

Academy of Management Learning and Education

Academy of Management Perspectives

Academy of Management Proceedings

Academy of Management Review

Rayen, Ine; L. van den Hove, Daniël; Prickaerts, Jos; W. Steinbusch, Harry; L. Pawluski, Jodi (2015). Fluoxetine during Development Reverses the Effects of Prenatal Stress on Depressive-Like Behavior and Hippocampal Neurogenesis in Adolescence. PLOS ONE. Collection. https://doi.org/10.1371/journal.pone.0024003

https://doi.org/10.1371/journal.pone.0024003

or

Select your citation style and then place your mouse over the citation text to select it.